Crescita Therapeutics Stock Market Value
| CRRTF Stock | USD 0.45 0.00 0.00% |
| Symbol | Crescita |
Crescita Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Crescita Therapeutics' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Crescita Therapeutics.
| 10/28/2024 |
| 11/27/2024 |
If you would invest 0.00 in Crescita Therapeutics on October 28, 2024 and sell it all today you would earn a total of 0.00 from holding Crescita Therapeutics or generate 0.0% return on investment in Crescita Therapeutics over 30 days. Crescita Therapeutics is related to or competes with Rezolute, Tempest Therapeutics, Forte Biosciences, Dyadic International, DiaMedica Therapeutics, Silo Pharma, and Molecular Partners. Crescita Therapeutics Inc., a dermatology company, provides non-prescription skincare products and prescription drug pro... More
Crescita Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Crescita Therapeutics' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Crescita Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | 0.1225 | |||
| Maximum Drawdown | 2097.0 |
Crescita Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Crescita Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Crescita Therapeutics' standard deviation. In reality, there are many statistical measures that can use Crescita Therapeutics historical prices to predict the future Crescita Therapeutics' volatility.| Risk Adjusted Performance | 0.104 | |||
| Jensen Alpha | 35.16 | |||
| Total Risk Alpha | (8.31) | |||
| Treynor Ratio | (1.06) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Crescita Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Crescita Therapeutics Backtested Returns
Crescita Therapeutics is out of control given 3 months investment horizon. Crescita Therapeutics secures Sharpe Ratio (or Efficiency) of 0.13, which signifies that the company had a 0.13% return per unit of standard deviation over the last 3 months. We were able to interpolate and analyze data for sixteen different technical indicators, which can help you to evaluate if expected returns of 15.84% are justified by taking the suggested risk. Use Crescita Therapeutics risk adjusted performance of 0.104, and Mean Deviation of 62.39 to evaluate company specific risk that cannot be diversified away. Crescita Therapeutics holds a performance score of 9 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of -29.73, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Crescita Therapeutics are expected to decrease by larger amounts. On the other hand, during market turmoil, Crescita Therapeutics is expected to outperform it. Use Crescita Therapeutics market risk adjusted performance, information ratio, as well as the relationship between the Information Ratio and rate of daily change , to analyze future returns on Crescita Therapeutics.
Auto-correlation | 0.00 |
No correlation between past and present
Crescita Therapeutics has no correlation between past and present. Overlapping area represents the amount of predictability between Crescita Therapeutics time series from 28th of October 2024 to 12th of November 2024 and 12th of November 2024 to 27th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Crescita Therapeutics price movement. The serial correlation of 0.0 indicates that just 0.0% of current Crescita Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Crescita Therapeutics lagged returns against current returns
Autocorrelation, which is Crescita Therapeutics pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Crescita Therapeutics' pink sheet expected returns. We can calculate the autocorrelation of Crescita Therapeutics returns to help us make a trade decision. For example, suppose you find that Crescita Therapeutics has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Crescita Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Crescita Therapeutics pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Crescita Therapeutics pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Crescita Therapeutics pink sheet over time.
Current vs Lagged Prices |
| Timeline |
Crescita Therapeutics Lagged Returns
When evaluating Crescita Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Crescita Therapeutics pink sheet have on its future price. Crescita Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Crescita Therapeutics autocorrelation shows the relationship between Crescita Therapeutics pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Crescita Therapeutics.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in Crescita Pink Sheet
Crescita Therapeutics financial ratios help investors to determine whether Crescita Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Crescita with respect to the benefits of owning Crescita Therapeutics security.